NEW YORK, Feb. 24, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
This report analyzes the worldwide markets for Drug-Eluting Stents in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2015. Also, a six-year historic analysis is provided for these markets. The report profiles 39 companies including many key and niche players such as Abbott Vascular, Angiotech Pharmaceuticals, Inc., AngioDynamics®, Inc., Boston Scientific, Inc., Boston Scientific Cardiac Rhythm Management, Biocompatibles International PLC, Biosensors International Pte Ltd., Cordis Corporation, Medtronic, Inc., MIV Therapeutics, Inc., and SurModics, Inc., Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
To order this report: